跳至主要内容
临床试验/NCT06396871
NCT06396871招募中不适用

Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases

Technische Universität Dresden1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2023年10月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
1
主要终点
Qualitative differences in platelets

研究概览

简要总结

The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question[s] it aims to answer are:

  • Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases
  • Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Additional inclusion criteria for case groups:
  • High risk group for significant liver fibrosis
  • FIB-4 score ≥ 1.3 AND
  • Fibroscan measurement ≥ 8kPa
  • Steatotic Liver Disease group
  • Diagnosis of steatosis in ultrasound AND CAP > 275 dB/m
  • Prediabetes
  • HbA1c >5.7 AND <6.5% OR/AND
  • Fasting Glucose 100-125 mg/dl OR/AND
  • Glucose at 120 min of OGTT between 140-200 mg/dl
  • HbA1c ≥ 6.5% OR/AND
  • Fasting Glucose > 126 mg/dl OR/AND
  • Glucose at 120 min of OGTT > 200 mg/dl
  • If a subject does not fulfil the additional criteria for participating in a case group, then he/she will be included in the respective control group which will be:
  • A#) Low risk for significant liver fibrosis
  • Fibroscan measurements < 8kPa B#) No steatosis group
  • No steatosis in liver ultrasound AND CAP ≤ 275 dB/m C#) Normal glucose tolerance test group
  • HbA1c < 5.7% AND
  • Fasting glucose < 100 mg/dl AND
  • Glucose at 120 min of OGTT <140 mg/dl

排除标准

  • Diabetes mellitus Typ 1
  • BMI < 18.5 kg/m2
  • Transfusion of blood or major bleeding in the last six months
  • Anaemia with haemoglobin < 9,0 g/dl
  • Chronic alcohol or drug abuse
  • Presence of any acute or chronic liver disease apart from non-alcoholic fatty liver disease (i.e. viral, autoimmune or alcoholic hepatitis, haemochromatosis, Morbus Wilson etc.)
  • Systemic infections (CRP > 1 mg/dl)
  • Medications that affect blood glucose levels (e.g. antidiabetics [except from the subjects forming the diabetes group], steroids) in the last six months
  • Medications that affect coagulation (e.g. anticoagulants and antiplatelet agents) in the last six months
  • Medications that affect immune function (e.g. immunosuppressive drugs) in the last six months
  • Pregnancy or breastfeeding
  • Severe psychic disorders
  • Inability to follow the study protocol
  • Have any medical condition unsuitable for inclusion in the study, in the opinion of the investigator
  • Additional exclusion criteria for MRI:
  • Artificial heart valve
  • Metal prosthesis
  • Implanted magnetic metal parts
  • Fixed metal dental braces
  • Acupuncture needle
  • Insulin pumps
  • By MRI > 3 Tesla: Tattoos, permanent eyeliner
  • Claustrophobia or any other condition, such as psychiatric disorder, that in the opinion of the investigator may prevent the participant from following and completing the protocol
  • Subject dimensions not allowing the performance of MRI

结局指标

主要结局

Qualitative differences in platelets

时间窗: 1 day

% of Platelet aggregation

Quantitative differences in platelets

时间窗: 1 day

Platelet count in GPt/L

次要结局

  • Qualitative differences in neutrophils in NETosis(1 day)
  • Quantitative differences in neutrophils(1 day)
  • Quantitative differences in leukocytes(1 day)
  • Quantitative differences in lymphocytes(1 day)
  • Qualitative differences in neutrophils in phagocytosis(1 day)
  • Quantitative differences in monocytes(1 day)
  • Quantitative differences in Interleukin-8(1 day)
  • Qualitative differences in monocytes(1 day)
  • Quantitative differences in Interleukin-6(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验